Related references
Note: Only part of the references are listed.Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea
Jee-Eun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients
Amy Kunchok et al.
JAMA NEUROLOGY (2020)
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
Yeseul Kim et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Markus Reindl et al.
NATURE REVIEWS NEUROLOGY (2019)
Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria
Yeseul Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2017)
Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases
Jae-Won Hyun et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
Sasitorn Siritho et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
Sasitorn Siritho et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
Sung-Min Kim et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Share Paper
